B. Braun, one of the largest medical technology companies in the world, headquartered in Germany, announced the expansion of its portfolio of testing capabilities for healthcare solutions related to intravenous access, surgical technologies, intravenous systems, central venous puncture and pain control; in Penang.
Prior to the expansion, the Global Test Centre based in Penang had only supported 200,000 scientific measurements per annum for medical devices related to intravenous access and drug delivery systems. Due to the proven competencies, strong product knowledge and efficiency displayed by the local team of Malaysian engineers, the volume of product testing has been tripled to more than 600,000 scientific measurements per annum. Furthermore, medical devices for infusion systems, central venous puncture and pain control, which are being manufactured in Germany, have also been added to the portfolio being tested in Penang.
The Global Test Centre conducts design validation, discovery and shelf life testing, as well as failure analysis; and features state-of-the art test equipment and a fully integrated data management system, which is crucial to ensure the safety and efficacy of medical devices, used in the treatment of patients around the world. All products are tested to ensure adherence to the stringent requirements of the European Medical Device Regulation (EU MDR), United States Food & Drug Administration (US FDA) and other recognised regulatory authorities.
Dato’ Azman Mahmud, Chief Executive Officer of the Malaysian Investment Development Authority (MIDA), said “The Malaysian medical device industry has indeed showed great promise in creating high quality employment, reinforcing the domestic supply chain ecosystem, and generating greater export value. We have a strong presence of established supporting industries conforming to world-class standards that support the medical devices industry in the country. The nation's legacy expertise in precision electronics has also provided our workforce the requisite skills in quality management and precision. We trust that these qualities draw world leaders in healthcare including B. Braun to continuously embrace the abundant business opportunities in Malaysia today.”
Mr. Lam Chee Hong, President of B. Braun Asia Pacific said, “For more than 180 years, B. Braun has protected and improved the health of people around the world, and we have built a strong reputation and trust among healthcare professionals for the safety and quality of our products and services. Staffed by a proven team of highly competent Malaysians, the Global Test Centre in Penang will further ensure that patients everywhere will continue to receive medical devices of the highest global standards.”
Occupying a 193,285 square metre (47.8 acres) site in Penang’s Free Industrial Zone, B. Braun Medical Industries is one of the largest production sites of the Group, with over 7,600 employees. Established in 1972, B. Braun is a pioneer foreign investor in the northern state, which has evolved into the nexus for the medical device industry in Malaysia. The site houses four production plants manufacturing intravenous access solutions, pharmaceutical products and surgical instruments for global markets; as well as the Group’s global Centre of Excellence for Intravenous Access with full R&D capabilities, and B. Braun’s Asia Pacific regional headquarters.
Media Statement
Tue Jun 02 2020
The Global Test Centre conducts design validation, discovery and shelf life testing. - Photo B. Braun
“Saya tak benarkan Diana buat bariatrik” - Farid Kamil
Farid lebih yakin hanya cara semula jadi lebih selamat untuk menurunkan berat badan.
Pemandu bas kilang ditahan, rempuh penunggang motosikal sehingga maut
Mangsa meninggal dunia di tempat kejadian selepas mengalami kecederaan parah di kepala.
Gagal capai sasaran, kerajaan tak boleh pandang ringan
Kegagalan Kerajaan untuk mencapai sasaran 30 juta pendaftar menjelang hujung bulan 3 ini harus dijadikan sebagai satu isyarat bahawa masih ada segelintir yang skeptikal tentang sistem Pangkalan Data Utama (PADU).
Kerajaan harus ambil cakna tentang keraguan orang ramai tentang sistem PADU sebagai satu mesej.
Menurut Presiden Persatuan Pengguna Siber Malaysia, Siraj Jali, masalah ini tercetus akibat kurangnya komunikasi yang cermat dan akhirnya,ia tercetus sebuah pemahaman yang bersegmen dan kompleks.
Kerajaan harus ambil cakna tentang keraguan orang ramai tentang sistem PADU sebagai satu mesej.
Menurut Presiden Persatuan Pengguna Siber Malaysia, Siraj Jali, masalah ini tercetus akibat kurangnya komunikasi yang cermat dan akhirnya,ia tercetus sebuah pemahaman yang bersegmen dan kompleks.
Arab Saudi dipilih pengerusikan Suruhanjaya Status Wanita (CSW) ke-69
Arab Saudi dipilih sebulat suara pada Rabu untuk mempengerusikan badan wanita Pertubuhan Bangsa-Bangsa Bersatu, Suruhanjaya Status Wanita (CSW).
Tokoh Wartawan Negara 2014, meninggal dunia
2014, Datuk Ahmad Rejal Arbee meninggal dunia di kediamannya 2 pagi Jumaat
ICJ arah Israel ambil tindakan atasi kebuluran di Gaza
ICJ berkata, rakyat Palestin di Gaza menghadapi keadaan hidup yang teruk, kelaparan dan kebuluran semakin meruncing.
Penipuan kewangan: Pengasas FTX, Sam Bankman-Fried dipenjara 25 tahun
Pengasas FTX, Sam Bankman-Fried dijatuhi hukuman penjara 25 tahun kerana penipuan mata wang kripto yang disifatkan sebagai salah satu penipuan kewangan terbesar dalam sejarah Amerika Syarikat.
OIC perlu tubuh pasukan pengaman
OIC perlu menubuhkan pasukan pengaman bagi menangani isu-isu berbangkit seperti penindasan ke atas rakyat Palestin.
Kekejaman zionis: PM Mustafa bentuk kabinet baharu Palestin
Perdana Menteri Palestin, Mohammad Mustafa membentuk kabinet baharu di mana beliau juga akan berkhidmat sebagai Menteri Luar.
Kekejaman zionis: ICJ arah Israel ambil tindakan atasi kebuluran di Gaza
Mahkamah Keadilan Antarabangsa (ICJ) sebulat suara mengarahkan Israel untuk mengambil semua tindakan yang perlu dan berkesan untuk memastikan bekalan makanan asas tiba tanpa berlengah-lengah kepada penduduk Palestin di Gaza.